Ken Yoshida, Tadashi Takenaka, Hironori Akiyama, Hideya Yamazaki, Mineo Yoshida, Koji Masui, Tadayuki Kotsuma, Sungjae Baek, Yasuo Uesugi, Taiju Shinbo, Nobuhiko Yoshikawa, Takumi Arika, Yukihiro Koretsune, Yasuo Yoshioka, Yoshifumi Narumi, Eiichi Tanaka：
Three-dimensional imaging-based high-dose-rate interstitial brachytherapy for mobile tongue cancer：
Journal of Radiation Research、55（1）：154-161、2014

Masaaki Higashino, Ryo Kawata, Koutetsu Lee, Shuji Nishikawa, Shimpei Ichihara, Yasuo Uesugi：
Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study：
Auris, nasus, larynx 、41：364-368、2014

Norihiro Aibe, Hideya Yamazaki, Takuya Nishimura, Yoshitaka Oota, Kazuki Iwama, Satoaki Nakamura, Hiroyasu Ikeno, Ken Yoshida, Haruumi Okabe , Kei Yamada:
Analysis of intrafractional organ motion by megavoltage computed tomography in patients with lung cancer treated with image-guided stereotactic body radiotherapy using helical tomotherapy:
Anticancer Research１、34:7383-7388、2014

Kazuki Iwama, Hideya Yamazaki, Takuya Nishimura, Yoshitaka Oota, Norihiro Aibe, Satoaki Nakamura, Hiroyasu Ikeno, Ken Yoshida, Haruumi Okabe:
Frequency and predisposing factors for interfractional rectal displacement requiring repeated precaution in prostate cancer patients treated with image-guided intensity-modulated radiation therapy:
Anticancer Research、34:7373-7378、2014

Hideya Yamazaki, Makio Ogita, Kengo Himei, Satoeki Nakamura, Ken Yoshida, Tadayuki Kotsuma, Kei Yamada, Masateru Fujiwara, Sung Jae Baek, Yasuo Yoshioka:
Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume:
Anticancer Research、34:5755-5759、2014

Hideya Yamazaki, Satoaki Nakamura, Takuya Nishimura, Ken Yoshida, Yasuo Yoshioka, Masahiko Koizumi, Kazuhiko Ogawa:
Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis:
Journal of Radiation Research、55:1033-1047、2014

Gen Suzuki, Hideya Yamazaki, Etsuyo Ogo, Toshi Abe, Hidehiro Eto, Koichiro Muraki, Chikayuki Hattori, Hirohito Umeno, Norimitsu Tanaka, Toshiaki Tanaka, Satoaki Nakamura, Ken Yoshida:
Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease:
Anticancer Research、34:5205-5210、2014

Ken Yoshida, Hideya Yamazaki, Satoaki Nakamura, Koji Masui, Tadayuki Kotsuma, Hironori Akiyama, Eiichi Tanaka, Yasuo Yoshioka:
Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy:
Anticancer Research、34:3077-3081、2014

Yasuo Yoshioka, Osamu Suzuki, Yuki Otani, Ken Yoshida, Takayuki Nose, Kazuhiko Ogawa:
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective:
Journal of Contemporary Brachytherapy、6:91-98、2014

Hironori Akiyama, Ken Yoshida, Hideya Yamazaki, Tadashi Takenaka, Tadayuki Kotsuma, Koji Masui, Yasuo Yoshioka, Takumi Arika, Kimishige Shimizutani, Eiichi Tanaka:
High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial:
Journal of Contemporary Brachytherapy、6:10-14、2014

Ken Yoshida, Hideya Yamazaki, Satoaki Nakamara, Koji Masui, Tadayuki Kotsuma, Hironori Akiyama, Eiichi Tanaka, Yasuo Yoshioka:
Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancer:
Anticancer Research、34:2015-2018、2014

Yasuo Yoshioka, Koji Konishi, Osamu Suzuki, Yasutomo Nakai, Fumiaki Isohashi, Yuji Seo , Yuki Otani, Masahiko Koizumi, Ken Yoshida, Hideya Yamazaki, Norio Nonomura, Kazuhiko Ogawa:
Monotherapeutic high-dose-rate brachytherapy for prostate cancer: a dose reduction trial.
Radiotherapy and Oncology、110:114-119、2014

Takuya Nishimura, Hideya Yamazaki, Kazuki Iwama, Yoshitaka Oota, Norihiro Aibe, Satoaki Nakamura, Ken Yoshida, Haruumi Okabe, Kei Yamada:
Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report:
Journal of Medical Case Reports、8:136、2014

Koji Masui, Ken Yoshida, Tadashi Takenaka, Tadayuki Kotsuma, Eiichi Tanaka, Keiji Tatsumi, Hideya Yamazaki, Kei Yamada:
A novel minimally invasive technique of high-dose rate image-based intracavitary brachytherapy for endometrial cancer using a single fine and soft, flexible applicator:
Anticancer Research、34:2537-2540、2014

Gen Suzuki, Hideya Yamazaki, Etsuyo Ogo, Toshi Abe, Hidehiro Eto, Koichiro Muraki, Chikayuki Hattori, Hirohito Umeno, Tadashi Nakashima, Tadashi Tanaka, Satoaki Nakamura, Ken Yoshida:
Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy:
Anticancer Research、34:1989-1992、2014

Gen Suzuki, Hideya Yamazaki, Etsuyo Ogo, Toshi Abe, Naofumi Hayabuchi, Hirohito Umeno, Tadashi Nakashima, Satoaki Nakamura, Ken Yoshida:
Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location:
Anticancer Research、34:203-207、2014

Ken Yoshida, Hideya Yamazaki, Tadashi Takenaka, Tadayuki Kotsuma, Mineo Yoshida, Koji Masui, Yasuo Yoshioka, Yoshifumi Narumi, Toshitsugu Oka, Eiichi Tanaka:
High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer
Are high-risk patients good candidates？:
Strahlentherapie und Onkologie、190：1015-1020、2014

Ken Yoshida, Hideya Yamazaki, Satoaki Nakamura, Koji Masui, Tadayuki Kotsuma, Hironori Akiyama, Eiichi Tanaka, Yoshifumi Narumi, Yasuo Yoshioka:
Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer:
Anticancer Research、34:4433-4438、2014